Carleton Goold

Carleton Goold is a Principal Scientist at Maze Therapeutics since March 2021. Prior to this role, they were a Senior Scientist at the same company from October 2018 to March 2021. Carleton also worked as a Senior Scientist, TRV NewCo at Third Rock Ventures from May 2018 to October 2018. Before that, Carleton served as an Investigator III at Novartis Institutes for BioMedical Research from August 2013 to May 2018. Carleton started their career as a Postdoctoral Fellow at Stanford University from November 2011 to July 2013.

Carleton Goold's education history includes an A.B. in Biochemical Sciences from Harvard University. The specific start and end years for this degree are not provided. Furthermore, Carleton Goold holds a Doctor of Philosophy (Ph.D.) in Neuroscience from the University of California, San Francisco. The duration of this degree program is also unspecified.